Filing Details

Accession Number:
0001209191-21-046026
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-08 18:13:38
Reporting Period:
2021-07-06
Accepted Time:
2021-07-08 18:13:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576885 Acumen Pharmaceuticals Inc. ABOS Biological Products, (No Disgnostic Substances) (2836) 364108129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1869596 B Nathan Fountain C/O Acumen Pharmaceuticals, Inc.
427 Park Street
Charlottesville VA 22902
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-07-06 6,250 $16.00 6,250 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct